Page last updated: 2024-08-24

6-sulfatoxymelatonin and Macular Degeneration

6-sulfatoxymelatonin has been researched along with Macular Degeneration in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cao, Z; Cheng, XC; Feng, XP; Gao, QF; Gong, LL; Hu, L; Liu, S; Lv, XD; Wang, J; Xing, YQ; Yu, CH1
Chen, M; Hu, DN; McCormick, SA; Perez, V; Rosen, R; Tai, K; Tone, P; Walsh, J; Yu, GP1

Other Studies

2 other study(ies) available for 6-sulfatoxymelatonin and Macular Degeneration

ArticleYear
Correlation between serum melatonin and aMT6S level for age-related macular degeneration patients.
    European review for medical and pharmacological sciences, 2016, Volume: 20, Issue:20

    Topics: Aged; Case-Control Studies; Female; Humans; Macular Degeneration; Male; Melatonin; Middle Aged; Odds Ratio; Risk Factors

2016
Urinary 6-sulfatoxymelatonin level in age-related macular degeneration patients.
    Molecular vision, 2009, Aug-21, Volume: 15

    Topics: Aged; Aging; Case-Control Studies; Creatinine; Demography; Female; Humans; Macular Degeneration; Male; Melatonin

2009